Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study.
Identifieur interne : 000127 ( Main/Exploration ); précédent : 000126; suivant : 000128Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study.
Auteurs : Birte Bödeker [Allemagne] ; Cornelius Remschmidt [Allemagne] ; Patrick Schmich [Allemagne] ; Ole Wichmann [Allemagne]Source :
- BMC public health [ 1471-2458 ] ; 2015.
Descripteurs français
- KwdFr :
- Acceptation des soins par les patients (psychologie), Acceptation des soins par les patients (statistiques et données numériques), Adolescent (MeSH), Adulte (MeSH), Adulte d'âge moyen (MeSH), Allemagne (épidémiologie), Connaissances, attitudes et pratiques en santé (MeSH), Entretiens comme sujet (MeSH), Facteurs socioéconomiques (MeSH), Femelle (MeSH), Grippe humaine (prévention et contrôle), Humains (MeSH), Jeune adulte (MeSH), Maladie chronique (épidémiologie), Mâle (MeSH), Prise de décision (MeSH), Probabilité (MeSH), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Vaccins antigrippaux (administration et posologie), Études transversales (MeSH).
- MESH :
- administration et posologie : Vaccins antigrippaux.
- prévention et contrôle : Grippe humaine.
- psychologie : Acceptation des soins par les patients.
- statistiques et données numériques : Acceptation des soins par les patients.
- épidémiologie : Allemagne, Maladie chronique.
- Adolescent, Adulte, Adulte d'âge moyen, Connaissances, attitudes et pratiques en santé, Entretiens comme sujet, Facteurs socioéconomiques, Femelle, Humains, Jeune adulte, Mâle, Prise de décision, Probabilité, Sujet âgé, Sujet âgé de 80 ans ou plus, Études transversales.
English descriptors
- KwdEn :
- Adolescent (MeSH), Adult (MeSH), Aged (MeSH), Aged, 80 and over (MeSH), Chronic Disease (epidemiology), Cross-Sectional Studies (MeSH), Decision Making (MeSH), Female (MeSH), Germany (epidemiology), Health Knowledge, Attitudes, Practice (MeSH), Humans (MeSH), Influenza Vaccines (administration & dosage), Influenza, Human (prevention & control), Interviews as Topic (MeSH), Male (MeSH), Middle Aged (MeSH), Patient Acceptance of Health Care (psychology), Patient Acceptance of Health Care (statistics & numerical data), Probability (MeSH), Socioeconomic Factors (MeSH), Young Adult (MeSH).
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- epidemiology : Chronic Disease, Germany.
- prevention & control : Influenza, Human.
- psychology : Patient Acceptance of Health Care.
- statistics & numerical data : Patient Acceptance of Health Care.
- Adolescent, Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Decision Making, Female, Health Knowledge, Attitudes, Practice, Humans, Interviews as Topic, Male, Middle Aged, Probability, Socioeconomic Factors, Young Adult.
Abstract
BACKGROUND
Older adults and individuals with underlying chronic diseases are at increased risk of developing influenza-related complications and are target groups for seasonal influenza vaccination in many countries. In Germany, an annual national information campaign is conducted to increase influenza vaccination uptake in the target groups. However, data are lacking on knowledge and attitudes toward influenza vaccination among older adults and those with chronic diseases. The present study aimed to (i) estimate influenza vaccination uptake for the 2012/13 and 2013/14 seasons, (ii) assess knowledge and attitudes about influenza vaccination, and (iii) identify factors associated with vaccination uptake in two risk groups.
METHODS
Between March and June 2014, we conducted a nationwide cross-sectional survey in adults (≥18 years) living in Germany using computer-assisted telephone interviewing. We calculated weighted vaccination coverage rates in two at-risk groups. Group 1 comprised participants aged 18-59 years with underlying chronic diseases. Group 2 comprised participants aged 60+, irrespective of underlying disease. We used univariate and multivariable logistic regression analyses to identify associations between influenza vaccination uptake and sociodemographic characteristics, and to evaluate attitudes and knowledge.
RESULTS
In total, 1,519 interviews were conducted. Seasonal influenza vaccination uptake in people with underlying chronic diseases aged 18-59 years was 24 % in 2012/2013 and 23 % in 2013/2014. In older adults, uptake was 50 % and 49 % in 2012/13 and 2013/14 respectively. There were considerable vaccination-related knowledge gaps among respondents. For example, about half of the participants who aged ≥60 years and/or suffered from underlying chronic diseases believed that influenza vaccination could cause influenza. The most commonly stated reasons for not being immunized were mistrust of the vaccination (22 %) and the perception that influenza is not dangerous (21 %). For both groups, vaccination uptake was independently associated with sex, perceived severity of influenza, perceived vaccination effectiveness, and the perceived likelihood or severity of vaccination side effects. For older adults, additional factors influencing vaccination uptake were age, underlying chronic diseases, and recent advice through physician consultation.
CONCLUSIONS
Influenza vaccination coverage rates in Germany remain low. Individual perceptions regarding harms and benefits are crucial in the decision-making process. Communication strategies should focus on improving understanding and perception of personal risks arising from the disease and the vaccination.
DOI: 10.1186/s12889-015-1970-4
PubMed: 26148480
PubMed Central: PMC4492002
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study.</title><author><name sortKey="Bodeker, Birte" sort="Bodeker, Birte" uniqKey="Bodeker B" first="Birte" last="Bödeker">Birte Bödeker</name><affiliation wicri:level="3"><nlm:affiliation>Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany. BoedekerB@rki.de.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Seestraße 10, 13353, Berlin</wicri:regionArea><placeName><region type="land" nuts="3">Berlin</region><settlement type="city">Berlin</settlement></placeName></affiliation></author><author><name sortKey="Remschmidt, Cornelius" sort="Remschmidt, Cornelius" uniqKey="Remschmidt C" first="Cornelius" last="Remschmidt">Cornelius Remschmidt</name><affiliation wicri:level="3"><nlm:affiliation>Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany. RemschmidtC@rki.de.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Seestraße 10, 13353, Berlin</wicri:regionArea><placeName><region type="land" nuts="3">Berlin</region><settlement type="city">Berlin</settlement></placeName></affiliation></author><author><name sortKey="Schmich, Patrick" sort="Schmich, Patrick" uniqKey="Schmich P" first="Patrick" last="Schmich">Patrick Schmich</name><affiliation wicri:level="3"><nlm:affiliation>Department of Epidemiology and Health Monitoring, Division of Health Interview Surveys and European Cooperation, Robert Koch Institute, General-Pape-Straße 62-66, 12101, Berlin, Germany. SchmichP@rki.de.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Epidemiology and Health Monitoring, Division of Health Interview Surveys and European Cooperation, Robert Koch Institute, General-Pape-Straße 62-66, 12101, Berlin</wicri:regionArea><placeName><region type="land" nuts="3">Berlin</region><settlement type="city">Berlin</settlement></placeName></affiliation></author><author><name sortKey="Wichmann, Ole" sort="Wichmann, Ole" uniqKey="Wichmann O" first="Ole" last="Wichmann">Ole Wichmann</name><affiliation wicri:level="3"><nlm:affiliation>Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany. WichmannO@rki.de.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Seestraße 10, 13353, Berlin</wicri:regionArea><placeName><region type="land" nuts="3">Berlin</region><settlement type="city">Berlin</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:26148480</idno><idno type="pmid">26148480</idno><idno type="doi">10.1186/s12889-015-1970-4</idno><idno type="pmc">PMC4492002</idno><idno type="wicri:Area/Main/Corpus">000127</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000127</idno><idno type="wicri:Area/Main/Curation">000127</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000127</idno><idno type="wicri:Area/Main/Exploration">000127</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study.</title><author><name sortKey="Bodeker, Birte" sort="Bodeker, Birte" uniqKey="Bodeker B" first="Birte" last="Bödeker">Birte Bödeker</name><affiliation wicri:level="3"><nlm:affiliation>Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany. BoedekerB@rki.de.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Seestraße 10, 13353, Berlin</wicri:regionArea><placeName><region type="land" nuts="3">Berlin</region><settlement type="city">Berlin</settlement></placeName></affiliation></author><author><name sortKey="Remschmidt, Cornelius" sort="Remschmidt, Cornelius" uniqKey="Remschmidt C" first="Cornelius" last="Remschmidt">Cornelius Remschmidt</name><affiliation wicri:level="3"><nlm:affiliation>Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany. RemschmidtC@rki.de.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Seestraße 10, 13353, Berlin</wicri:regionArea><placeName><region type="land" nuts="3">Berlin</region><settlement type="city">Berlin</settlement></placeName></affiliation></author><author><name sortKey="Schmich, Patrick" sort="Schmich, Patrick" uniqKey="Schmich P" first="Patrick" last="Schmich">Patrick Schmich</name><affiliation wicri:level="3"><nlm:affiliation>Department of Epidemiology and Health Monitoring, Division of Health Interview Surveys and European Cooperation, Robert Koch Institute, General-Pape-Straße 62-66, 12101, Berlin, Germany. SchmichP@rki.de.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Epidemiology and Health Monitoring, Division of Health Interview Surveys and European Cooperation, Robert Koch Institute, General-Pape-Straße 62-66, 12101, Berlin</wicri:regionArea><placeName><region type="land" nuts="3">Berlin</region><settlement type="city">Berlin</settlement></placeName></affiliation></author><author><name sortKey="Wichmann, Ole" sort="Wichmann, Ole" uniqKey="Wichmann O" first="Ole" last="Wichmann">Ole Wichmann</name><affiliation wicri:level="3"><nlm:affiliation>Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany. WichmannO@rki.de.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Seestraße 10, 13353, Berlin</wicri:regionArea><placeName><region type="land" nuts="3">Berlin</region><settlement type="city">Berlin</settlement></placeName></affiliation></author></analytic><series><title level="j">BMC public health</title><idno type="eISSN">1471-2458</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term><term>Adult (MeSH)</term><term>Aged (MeSH)</term><term>Aged, 80 and over (MeSH)</term><term>Chronic Disease (epidemiology)</term><term>Cross-Sectional Studies (MeSH)</term><term>Decision Making (MeSH)</term><term>Female (MeSH)</term><term>Germany (epidemiology)</term><term>Health Knowledge, Attitudes, Practice (MeSH)</term><term>Humans (MeSH)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza, Human (prevention & control)</term><term>Interviews as Topic (MeSH)</term><term>Male (MeSH)</term><term>Middle Aged (MeSH)</term><term>Patient Acceptance of Health Care (psychology)</term><term>Patient Acceptance of Health Care (statistics & numerical data)</term><term>Probability (MeSH)</term><term>Socioeconomic Factors (MeSH)</term><term>Young Adult (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Acceptation des soins par les patients (psychologie)</term><term>Acceptation des soins par les patients (statistiques et données numériques)</term><term>Adolescent (MeSH)</term><term>Adulte (MeSH)</term><term>Adulte d'âge moyen (MeSH)</term><term>Allemagne (épidémiologie)</term><term>Connaissances, attitudes et pratiques en santé (MeSH)</term><term>Entretiens comme sujet (MeSH)</term><term>Facteurs socioéconomiques (MeSH)</term><term>Femelle (MeSH)</term><term>Grippe humaine (prévention et contrôle)</term><term>Humains (MeSH)</term><term>Jeune adulte (MeSH)</term><term>Maladie chronique (épidémiologie)</term><term>Mâle (MeSH)</term><term>Prise de décision (MeSH)</term><term>Probabilité (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Sujet âgé de 80 ans ou plus (MeSH)</term><term>Vaccins antigrippaux (administration et posologie)</term><term>Études transversales (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Chronic Disease</term><term>Germany</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Acceptation des soins par les patients</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Patient Acceptance of Health Care</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Patient Acceptance of Health Care</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Acceptation des soins par les patients</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Allemagne</term><term>Maladie chronique</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Cross-Sectional Studies</term><term>Decision Making</term><term>Female</term><term>Health Knowledge, Attitudes, Practice</term><term>Humans</term><term>Interviews as Topic</term><term>Male</term><term>Middle Aged</term><term>Probability</term><term>Socioeconomic Factors</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Connaissances, attitudes et pratiques en santé</term><term>Entretiens comme sujet</term><term>Facteurs socioéconomiques</term><term>Femelle</term><term>Humains</term><term>Jeune adulte</term><term>Mâle</term><term>Prise de décision</term><term>Probabilité</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Études transversales</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Older adults and individuals with underlying chronic diseases are at increased risk of developing influenza-related complications and are target groups for seasonal influenza vaccination in many countries. In Germany, an annual national information campaign is conducted to increase influenza vaccination uptake in the target groups. However, data are lacking on knowledge and attitudes toward influenza vaccination among older adults and those with chronic diseases. The present study aimed to (i) estimate influenza vaccination uptake for the 2012/13 and 2013/14 seasons, (ii) assess knowledge and attitudes about influenza vaccination, and (iii) identify factors associated with vaccination uptake in two risk groups.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>Between March and June 2014, we conducted a nationwide cross-sectional survey in adults (≥18 years) living in Germany using computer-assisted telephone interviewing. We calculated weighted vaccination coverage rates in two at-risk groups. Group 1 comprised participants aged 18-59 years with underlying chronic diseases. Group 2 comprised participants aged 60+, irrespective of underlying disease. We used univariate and multivariable logistic regression analyses to identify associations between influenza vaccination uptake and sociodemographic characteristics, and to evaluate attitudes and knowledge.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>In total, 1,519 interviews were conducted. Seasonal influenza vaccination uptake in people with underlying chronic diseases aged 18-59 years was 24 % in 2012/2013 and 23 % in 2013/2014. In older adults, uptake was 50 % and 49 % in 2012/13 and 2013/14 respectively. There were considerable vaccination-related knowledge gaps among respondents. For example, about half of the participants who aged ≥60 years and/or suffered from underlying chronic diseases believed that influenza vaccination could cause influenza. The most commonly stated reasons for not being immunized were mistrust of the vaccination (22 %) and the perception that influenza is not dangerous (21 %). For both groups, vaccination uptake was independently associated with sex, perceived severity of influenza, perceived vaccination effectiveness, and the perceived likelihood or severity of vaccination side effects. For older adults, additional factors influencing vaccination uptake were age, underlying chronic diseases, and recent advice through physician consultation.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>Influenza vaccination coverage rates in Germany remain low. Individual perceptions regarding harms and benefits are crucial in the decision-making process. Communication strategies should focus on improving understanding and perception of personal risks arising from the disease and the vaccination.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">26148480</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2015</Year><Month>Jul</Month><Day>07</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study.</ArticleTitle><Pagination><MedlinePgn>618</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-015-1970-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Older adults and individuals with underlying chronic diseases are at increased risk of developing influenza-related complications and are target groups for seasonal influenza vaccination in many countries. In Germany, an annual national information campaign is conducted to increase influenza vaccination uptake in the target groups. However, data are lacking on knowledge and attitudes toward influenza vaccination among older adults and those with chronic diseases. The present study aimed to (i) estimate influenza vaccination uptake for the 2012/13 and 2013/14 seasons, (ii) assess knowledge and attitudes about influenza vaccination, and (iii) identify factors associated with vaccination uptake in two risk groups.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Between March and June 2014, we conducted a nationwide cross-sectional survey in adults (≥18 years) living in Germany using computer-assisted telephone interviewing. We calculated weighted vaccination coverage rates in two at-risk groups. Group 1 comprised participants aged 18-59 years with underlying chronic diseases. Group 2 comprised participants aged 60+, irrespective of underlying disease. We used univariate and multivariable logistic regression analyses to identify associations between influenza vaccination uptake and sociodemographic characteristics, and to evaluate attitudes and knowledge.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 1,519 interviews were conducted. Seasonal influenza vaccination uptake in people with underlying chronic diseases aged 18-59 years was 24 % in 2012/2013 and 23 % in 2013/2014. In older adults, uptake was 50 % and 49 % in 2012/13 and 2013/14 respectively. There were considerable vaccination-related knowledge gaps among respondents. For example, about half of the participants who aged ≥60 years and/or suffered from underlying chronic diseases believed that influenza vaccination could cause influenza. The most commonly stated reasons for not being immunized were mistrust of the vaccination (22 %) and the perception that influenza is not dangerous (21 %). For both groups, vaccination uptake was independently associated with sex, perceived severity of influenza, perceived vaccination effectiveness, and the perceived likelihood or severity of vaccination side effects. For older adults, additional factors influencing vaccination uptake were age, underlying chronic diseases, and recent advice through physician consultation.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Influenza vaccination coverage rates in Germany remain low. Individual perceptions regarding harms and benefits are crucial in the decision-making process. Communication strategies should focus on improving understanding and perception of personal risks arising from the disease and the vaccination.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bödeker</LastName><ForeName>Birte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany. BoedekerB@rki.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Remschmidt</LastName><ForeName>Cornelius</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany. RemschmidtC@rki.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmich</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Health Monitoring, Division of Health Interview Surveys and European Cooperation, Robert Koch Institute, General-Pape-Straße 62-66, 12101, Berlin, Germany. SchmichP@rki.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wichmann</LastName><ForeName>Ole</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany. WichmannO@rki.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>07</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003657" MajorTopicYN="N">Decision Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="Y">Health Knowledge, Attitudes, Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007407" MajorTopicYN="N">Interviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011336" MajorTopicYN="N">Probability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>03</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>06</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26148480</ArticleId><ArticleId IdType="doi">10.1186/s12889-015-1970-4</ArticleId><ArticleId IdType="pii">10.1186/s12889-015-1970-4</ArticleId><ArticleId IdType="pmc">PMC4492002</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Can J Aging. 2014 Mar;33(1):92-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24289886</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2014 Jan 9;32(3):350-4</Citation><ArticleIdList><ArticleId IdType="pubmed">24269621</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiol Infect. 2013 Feb;141(2):377-89</Citation><ArticleIdList><ArticleId IdType="pubmed">22717154</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Infect Control. 2014 May;42(5):e55-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24773805</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2014;19(16):20780</Citation><ArticleIdList><ArticleId IdType="pubmed">24786262</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2014;10(2):449-55</Citation><ArticleIdList><ArticleId IdType="pubmed">24280728</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2014 Jul 16;32(33):4131-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24928791</ArticleId></ArticleIdList></Reference><Reference><Citation>Przegl Epidemiol. 2014;68(3):455-63, 559-65</Citation><ArticleIdList><ArticleId IdType="pubmed">25391010</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Feb;58(2):174-81</Citation><ArticleIdList><ArticleId IdType="pubmed">25446313</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2012 Apr 25;307(16):1702-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22535855</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2012;17(14). pii: 20138</Citation><ArticleIdList><ArticleId IdType="pubmed">22516003</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2012 Feb 1;30(6):1143-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22192850</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin. 2011 Dec;7(12):1317-25</Citation><ArticleIdList><ArticleId IdType="pubmed">22108034</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Infect Dis. 2011;11:205</Citation><ArticleIdList><ArticleId IdType="pubmed">21798074</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2011 Jun 15;29(27):4492-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21545822</ArticleId></ArticleIdList></Reference><Reference><Citation>Dtsch Arztebl Int. 2010 Dec;107(48):845-50</Citation><ArticleIdList><ArticleId IdType="pubmed">21173931</ArticleId></ArticleIdList></Reference><Reference><Citation>J Adv Nurs. 2010 Oct;66(10):2297-308</Citation><ArticleIdList><ArticleId IdType="pubmed">20722815</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 2010 Nov;123(11):1031-5</Citation><ArticleIdList><ArticleId IdType="pubmed">20843496</ArticleId></ArticleIdList></Reference><Reference><Citation>Ned Tijdschr Geneeskd. 2010;154:A1686</Citation><ArticleIdList><ArticleId IdType="pubmed">20482914</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Nurs. 2008 Jan;17(1):5-16</Citation><ArticleIdList><ArticleId IdType="pubmed">17394537</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Vaccin Immunother. 2015;11(1):198-205</Citation><ArticleIdList><ArticleId IdType="pubmed">25483536</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Gen Pract. 2007 May;57(538):352-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17504584</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Psychol. 2007 Mar;26(2):136-45</Citation><ArticleIdList><ArticleId IdType="pubmed">17385964</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiol Infect. 2007 Jan;135(1):139-43</Citation><ArticleIdList><ArticleId IdType="pubmed">16740194</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2006 Sep;49(9):853-60</Citation><ArticleIdList><ArticleId IdType="pubmed">16927038</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2006 Jun 29;24(26):5526-34</Citation><ArticleIdList><ArticleId IdType="pubmed">16716461</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2006 Mar 24;24(14):2560-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16414160</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2006 Jan 30;24(5):622-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16169638</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004 Dec;47(12):1182-8</Citation><ArticleIdList><ArticleId IdType="pubmed">15583889</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Prev Med. 1991 Jul-Aug;7(4):199-203</Citation><ArticleIdList><ArticleId IdType="pubmed">1756055</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Gen Pract. 2007 May;57(538):359-63</Citation><ArticleIdList><ArticleId IdType="pubmed">17504585</ArticleId></ArticleIdList></Reference><Reference><Citation>Presse Med. 2012 Nov;41(11):e568-76</Citation><ArticleIdList><ArticleId IdType="pubmed">22795870</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2012;12:938</Citation><ArticleIdList><ArticleId IdType="pubmed">23113995</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Jan;56(1):124-30</Citation><ArticleIdList><ArticleId IdType="pubmed">23275965</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2013;13:388</Citation><ArticleIdList><ArticleId IdType="pubmed">23617788</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ. 2013;347:f5061</Citation><ArticleIdList><ArticleId IdType="pubmed">23974637</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Vaccines. 2013 Aug;12(8):893-901</Citation><ArticleIdList><ArticleId IdType="pubmed">23944683</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Sep;56(9):1270-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23990089</ArticleId></ArticleIdList></Reference><Reference><Citation>Wkly Epidemiol Rec. 2012 May 25;87(21):201-16</Citation><ArticleIdList><ArticleId IdType="pubmed">24340402</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2014 Feb 27;370(9):789-91</Citation><ArticleIdList><ArticleId IdType="pubmed">24450860</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Allemagne</li></country><region><li>Berlin</li></region><settlement><li>Berlin</li></settlement></list><tree><country name="Allemagne"><region name="Berlin"><name sortKey="Bodeker, Birte" sort="Bodeker, Birte" uniqKey="Bodeker B" first="Birte" last="Bödeker">Birte Bödeker</name></region><name sortKey="Remschmidt, Cornelius" sort="Remschmidt, Cornelius" uniqKey="Remschmidt C" first="Cornelius" last="Remschmidt">Cornelius Remschmidt</name><name sortKey="Schmich, Patrick" sort="Schmich, Patrick" uniqKey="Schmich P" first="Patrick" last="Schmich">Patrick Schmich</name><name sortKey="Wichmann, Ole" sort="Wichmann, Ole" uniqKey="Wichmann O" first="Ole" last="Wichmann">Ole Wichmann</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeAllemagneV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000127 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000127 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeAllemagneV4
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:26148480
|texte= Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:26148480" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeAllemagneV4
| This area was generated with Dilib version V0.6.35. |  |